Flying with nut and other food allergies: unravelling fact from fiction
- PMID: 39414343
- PMCID: PMC12013556
- DOI: 10.1136/archdischild-2024-327848
Flying with nut and other food allergies: unravelling fact from fiction
Abstract
There is a common perception that peanut/tree nut particles can be transmitted through aircraft ventilation systems and pose a significant risk to passengers with food allergies. In fact, food-induced allergic reactions are around 10-100 times less common during flights than 'on the ground', perhaps because of the multiple precautions food-allergic passengers take when flying. We review the evidence for strategies to help prevent accidental allergic reactions while travelling on commercial flights (review registered at PROSPERO, ref CRD42022384341). Research studies (including aircraft simulations) show no evidence to support airborne transmission of nut allergens as a likely phenomenon. Announcements requesting 'nut bans' are not therefore supported, and may instal a false sense of security. The most effective measure is for passengers to wipe down their seat area (including tray table and seat-back entertainment system). Food proteins are often 'sticky' and adhere to these surfaces, from where they are easily transferred to a person's hands and onto food that might be consumed. Airline companies can help to facilitate this through pre-boarding. Passengers at risk of anaphylaxis should be prescribed two adrenaline [epinephrine] autoinjector devices, to carry on their person at all times-including when flying. Airlines should consider including a separate supply of 'general use' adrenaline autoinjectors in the onboard medical kit for use in an emergency. All airlines should have clear policies relating to food allergies which are easily available from their websites or on request. These policies should be applied consistently by both ground staff and cabin crew, in order to provide reassurance to food-allergic passengers and their caregivers.
Keywords: Allergy; Allergy and Immunology; Child Health; Paediatrics.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf. PT declares grants from UK Medical Research Council and contracted funding from the UK Civil Aviation Authority for the submitted work; grants from the UK Food Standards Agency, The Jon Moulton Charity Trust, NIHR/Imperial Biomedical Research Centre and End Allergies Together, outside the submitted work; personal fees from UK Food Standards Agency, DBV Technologies, Aimmune Therapeutics, ALK and Allergenis outside the submitted work. ND was Head of Aviation Health Unit at the UK Civil Aviation Authority until 2022, during which time he helped secure funding for this work. He is now self-employed as an independent consultant in aviation medicine.
Figures




References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical